Gastrointestinal and Health-related Quality of Life Outcomes in Patients With Simultaneous Pancreas-Kidney Transplants

NCT00267150 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreas Transplantation
Kidney Transplantation

Interventions

DRUG: Enteric-coated mycophenolate sodium (EC-MPS)

Sponsor

Novartis Pharmaceuticals